Deerfield Special Situations International Master Fund, L.P.
Insider CIK 1565099 · PRTO 10% owner · DRNA 10% owner · TRIV 10% owner · ASPX 10% owner · AAVL 10% owner · LOXO 10% owner · CASM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CASM CAS MEDICAL SYSTEMS INC | P Buy | 2015-01-01 | 2015-01-05 | 1,443,200 | $1.65 | $2.38M | 3,200,000 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | S Sale | 2015-01-01 | 2015-01-05 | 1,443,200 | $1.65 | $2.38M | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-07 | 2014-11-10 | 3,500 | $9.27 | $32.4K | 30,100 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-07 | 2014-11-10 | 30,100 | $9.33 | $280.8K | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-07 | 2014-11-10 | 180,564 | $9.00 | $1.63M | 33,600 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-27 | 1,311,840 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-27 | 1,047,584 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-27 | 6,134,501 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-27 | 4,907,601 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-27 | 838,067 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-27 | 1,049,472 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 55 | $10.00 | $550 | 208,345 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 272 | $10.00 | $2.7K | 170,326 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 328 | $10.00 | $3.3K | 208,290 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 12,819 | $10.00 | $128.2K | 170,054 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 15,417 | $10.00 | $154.2K | 207,962 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 5,801 | $10.00 | $58.0K | 157,235 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 6,976 | $10.00 | $69.8K | 192,545 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 81,949 | $10.00 | $819.5K | 151,434 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 45 | $10.00 | $450 | 170,371 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 469,495 | $10.00 | $4.69M | 876,391 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-27 | 69,485 | — | $0 | 69,485 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-27 | 87,013 | — | $0 | 87,013 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-27 | 406,896 | — | $0 | 406,896 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-27 | 98,556 | $10.00 | $985.6K | 185,569 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-15 | 2014-10-15 | 51,449 | $10.01 | $515.0K | 214,164 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-14 | 2014-10-15 | 14,464 | $11.02 | $159.4K | 946,077 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-14 | 2014-10-15 | 12,622 | $11.02 | $139.1K | 825,603 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-14 | 2014-10-15 | 4,061 | $11.02 | $44.8K | 265,613 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-14 | 2014-10-15 | 4,968 | $11.02 | $54.7K | 324,947 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 4,072 | $12.14 | $49.4K | 329,999 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 246 | $12.00 | $3.0K | 960,541 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 215 | $12.00 | $2.6K | 838,225 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 69 | $12.00 | $828 | 269,674 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 84 | $12.00 | $1.0K | 330 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 11,855 | $12.14 | $143.9K | 960,787 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 10,345 | $12.14 | $125.6K | 838,440 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 3,328 | $12.14 | $40.4K | 269,743 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 279,051 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 222,839 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 176,900 | $13.00 | $2.30M | 176,900 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 62,400 | $13.05 | $814.3K | 239,300 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 246,631 | $13.00 | $3.21M | 469,470 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 222,839 | — | $0 | 222,839 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 307,600 | $13.00 | $4.00M | 586,651 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 218,869 | $13.00 | $2.85M | 218,869 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 77,256 | $13.05 | $1.01M | 296,125 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 279,051 | — | $0 | 279,051 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion deriv | 2014-08-05 | 2014-08-05 | 147,410 | — | $0 | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion deriv | 2014-08-05 | 2014-08-05 | 531,208 | — | $0 | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion deriv | 2014-08-05 | 2014-08-05 | 184,594 | — | $0 | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 22,400 | $26.14 | $585.5K | 441,200 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 10,100 | $27.54 | $278.2K | 418,800 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 177,700 | $26.42 | $4.69M | 408,700 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 15,100 | $25.79 | $389.4K | 231,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 7,900 | $25.52 | $201.6K | 215,900 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 163,300 | $25.41 | $4.15M | 208,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 44,700 | $17.00 | $759.9K | 44,700 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 34,223 | $17.00 | $581.8K | 181,633 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 42,700 | $17.00 | $725.9K | 227,294 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion | 2014-08-05 | 2014-08-05 | 531,208 | — | $0 | 531,208 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion | 2014-08-05 | 2014-08-05 | 147,410 | — | $0 | 147,410 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion | 2014-08-05 | 2014-08-05 | 184,594 | — | $0 | 184,594 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 31,650 | $24.57 | $777.6K | 627,267 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 49,981 | $26.35 | $1.32M | 595,617 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 40,400 | $26.35 | $1.06M | 481,600 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 25,600 | $24.57 | $629.0K | 507,200 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 55,300 | $17.00 | $940.1K | 55,300 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 201,972 | $25.41 | $5.13M | 257,272 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 9,800 | $25.52 | $250.1K | 267,072 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 18,700 | $25.79 | $482.3K | 285,772 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 219,864 | $26.42 | $5.81M | 505,636 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 12,400 | $27.54 | $341.5K | 518,036 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 27,600 | $26.14 | $721.5K | 545,636 | SEC↗ |
| AAVL Avalanche Biotechnologies, | P Buy | 2014-08-05 | 2014-08-05 | 123,077 | $17.00 | $2.09M | 654,285 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-22 | 71,333 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-22 | 86,834 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-22 | 221,118 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-22 | 253,384 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 94,520 | $11.97 | $1.13M | 324,524 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 75,480 | $11.97 | $903.5K | 261,143 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-22 | 86,834 | — | $0 | 86,834 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-22 | 71,333 | — | $0 | 71,333 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-22 | 221,118 | — | $0 | 221,118 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 118,150 | $12.00 | $1.42M | 204,984 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-22 | 253,384 | — | $0 | 253,384 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 19,980 | $12.29 | $245.6K | 185,663 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 25,020 | $12.29 | $307.5K | 230,004 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 340,425 | $12.00 | $4.09M | 593,809 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 297,075 | $12.00 | $3.56M | 518,193 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 94,350 | $12.00 | $1.13M | 165,683 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-11 | 796,114 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-11 | 654,002 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-11 | 2,323,086 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-11 | 2,027,262 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-11 | 145,333 | — | $0 | 223,733 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-11 | 450,502 | — | $0 | 695,152 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-11 | 516,241 | — | $0 | 796,591 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-11 | 96,600 | $12.00 | $1.16M | 273,514 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-11 | 78,400 | $12.00 | $940.8K | 223,733 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-11 | 244,650 | $12.00 | $2.94M | 695,152 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-11 | 280,350 | $12.00 | $3.36M | 796,591 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-11 | 176,914 | — | $0 | 273,514 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 572,142 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 161,071 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 196,071 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 499,285 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-04 | 349,500 | $15.00 | $5.24M | 848,785 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-04 | 112,000 | $15.00 | $1.68M | 273,071 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-04 | 138,000 | $15.00 | $2.07M | 334,071 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-04 | 400,500 | $15.00 | $6.01M | 972,642 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 572,142 | — | $0 | 972,642 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 499,285 | — | $0 | 848,785 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 161,071 | — | $0 | 273,071 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 196,071 | — | $0 | 334,071 | SEC↗ |